INFORMATION

Psicothema was founded in Asturias (northern Spain) in 1989, and is published jointly by the Psychology Faculty of the University of Oviedo and the Psychological Association of the Principality of Asturias (Colegio Oficial de Psicología del Principado de Asturias).
We currently publish four issues per year, which accounts for some 100 articles annually. We admit work from both the basic and applied research fields, and from all areas of Psychology, all manuscripts being anonymously reviewed prior to publication.

PSICOTHEMA
  • Director: Laura E. Gómez Sánchez
  • Frequency:
         February | May | August | November
  • ISSN: 0214-9915
  • Digital Edition:: 1886-144X
CONTACT US
  • Address: Ildelfonso Sánchez del Río, 4, 1º B
    33001 Oviedo (Spain)
  • Phone: 985 285 778
  • Fax: 985 281 374
  • Email:psicothema@cop.es

Psicothema, 2011. Vol. Vol. 23 (nº 3). 374-381




Repercusión de la ansiedad y depresión en el estado físico y funcionalidad de enfermos oncológicos durante el tratamiento con quimioterapia

Concepción Fernández Rodríguez1, Celina Padierna Sánchez2, Erica Villoria Fernández1, Isaac Amigo Vázquez1,Roberto Fernández Martínez3 e Ignacio Peláez Fernández3


1 Universidad de Oviedo, 2 Hospital Central de Asturias y 3 Hospital de Cabueñes

Se describe la evolución de la sintomatología, estado emocional y rutinas cotidianas en pacientes con cáncer de mama y cáncer de pulmón durante el tratamiento con quimioterapia (QT), y se analiza la mediación de la ansiedad y depresión en el estado físico y funcionalidad. 66 pacientes, 29 con cáncer de mama y 37 con cáncer de pulmón, se evalúan antes de iniciar el tratamiento, finalizado el primero, segundo y último ciclo de QT, mediante el HAD, escalas de apreciación y entrevista. Menos de un 30% alcanzan puntuaciones en el HAD indicativas patología ansiosa o depresiva. Se incrementó significativamente el cansancio, fatiga y náuseas y se interrumpen las actividades laborales y de ocio. La preocupación por el futuro de allegados y el insomnio se incrementan significativamente a lo largo del tiempo en pacientes con cáncer de mama, mientras que se reducen en pacientes con cáncer de pulmón. Al introducir como covariables las puntuaciones obtenidas en el HAD, se comprueba que la mayoría de diferencias son atribuibles a los factores tiempo y tipo de cáncer. Las alteraciones emocionales no parecen tener, durante el tratamiento con QT, un peso relevante en la sintomatología y cambios en la vida cotidiana referidos por el paciente oncológico.

Impact of anxiety and depression on the physical status and daily routines of cancer patients during chemotherapy. The evolution of symptoms, emotional state and daily routines in patients with breast cancer and lung cancer during treatment with intravenous chemotherapy (CT) is described and the influence of anxiety and depression on these variables is analyzed. 66 patients, 29 with breast cancer and 37 with lung cancer, were evaluated before starting treatment, and after completing the first, second and last cycle of CT using the Hospital Anxiety and Depression Scale (HADS), rating scales and interview. Less than 30% of the patients showed clinical anxiety or depression according to the HADS. Throughout the treatment, tiredness, fatigue and nausea increased significantly and work and leisure activity decreased. Concern about the future of relatives and insomnia increased significantly over time in patients with breast cancer whereas they decreased in patients with lung cancer. By introducing the HADS scores as covariates, it was found that most differences are due to the time factor and the type of cancer. During treatment with CT, emotional disturbances do not seem to have significant impact on the symptoms and changes in daily life reported by cancer patients.

PDF

Impact Factor JCR SSCI Clarivate 2023 = 3.2 (Q1) / CiteScore SCOPUS 2023 = 6.5 (Q1)